Ho RJ[au] - Search Results

Year	Number of Results
1964	2
1965	2
1966	2
1967	3
1969	1
1970	5
1971	2
1972	1
1973	1
1975	5
1977	1
1978	3
1979	1
1980	1
1981	3
1983	2
1984	1
1985	1
1986	8
1987	2
1988	2
1989	1
1990	1
1991	1
1992	1
1993	1
1994	7
1995	6
1996	2
1997	4
1998	1
1999	3
2000	5
2001	4
2002	2
2003	3
2004	6
2005	4
2006	6
2007	4
2008	7
2009	2
2010	5
2011	9
2012	5
2013	3
2014	9
2015	11
2016	5
2017	5
2018	9
2019	4
2020	14
2021	9
2022	6

1

Editorial: human genome information.

Ho RJ. Ho RJ. J Pharm Sci. 2011 Oct;100(10):4045-6. doi: 10.1002/jps.22713. Epub 2011 Jul 20. J Pharm Sci. 2011. PMID: 21780123 Free PMC article. No abstract available.

2

Optimizing a Novel Au-Grafted Lipid Nanoparticle Through Chelation Chemistry for High Photothermal Biologic Activity.

Gao Y, Mu Q, Zhu L, Li Z, Ho RJY. Gao Y, et al. Among authors: ho rjy. J Pharm Sci. 2020 May;109(5):1780-1788. doi: 10.1016/j.xphs.2020.02.010. Epub 2020 Feb 18. J Pharm Sci. 2020. PMID: 32081720

3

Advancing Cell and Gene Therapeutic Products for Health Impact - Progress on Pharmaceutical Research, Development, Manufacturing and Controls.

Bak A, Ho RJY. Bak A, et al. Among authors: ho rjy. J Pharm Sci. 2021 May;110(5):1869-1870. doi: 10.1016/j.xphs.2020.10.053. Epub 2020 Nov 13. J Pharm Sci. 2021. PMID: 33189694 No abstract available.

4

Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.

Mu Q, Yu J, McConnachie LA, Kraft JC, Gao Y, Gulati GK, Ho RJY. Mu Q, et al. Among authors: ho rjy. J Drug Target. 2018 Jun-Jul;26(5-6):435-447. doi: 10.1080/1061186X.2017.1419363. Epub 2018 Jan 10. J Drug Target. 2018. PMID: 29285948 Free PMC article. Review.

5

A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.

Lan JS, Qin YH, Liu L, Zeng RF, Yang Y, Wang K, Ding Y, Zhang T, Ho RJY. Lan JS, et al. Among authors: ho rjy. Int J Nanomedicine. 2021 Mar 3;16:1775-1787. doi: 10.2147/IJN.S287806. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33692622 Free PMC article.

6

Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private Partnerships.

Ho RJY. Ho RJY. J Pharm Sci. 2021 Feb;110(2):615-618. doi: 10.1016/j.xphs.2020.11.010. Epub 2020 Nov 17. J Pharm Sci. 2021. PMID: 33212162 Free PMC article.

7

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective.

Perazzolo S, Zhu L, Lin W, Nguyen A, Ho RJY. Perazzolo S, et al. Among authors: ho rjy. J Pharm Sci. 2021 Mar;110(3):1002-1017. doi: 10.1016/j.xphs.2020.11.019. Epub 2020 Nov 26. J Pharm Sci. 2021. PMID: 33248057 Free PMC article.

8

Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.

Gao Y, Kraft JC, Yu D, Ho RJY. Gao Y, et al. Among authors: ho rjy. Eur J Pharm Biopharm. 2019 May;138:75-91. doi: 10.1016/j.ejpb.2018.04.014. Epub 2018 Apr 17. Eur J Pharm Biopharm. 2019. PMID: 29678735 Free PMC article. Review.

9

ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models.

Zhu L, Mu Q, Yu J, Griffin JI, Xu X, Ho RJY. Zhu L, et al. Among authors: ho rjy. Pharmaceutics. 2021 Dec 31;14(1):89. doi: 10.3390/pharmaceutics14010089. Pharmaceutics. 2021. PMID: 35056985 Free PMC article.

10

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII.

Lu L, Ding Y, Zhang Y, Ho RJ, Zhao Y, Zhang T, Guo C. Lu L, et al. Among authors: ho rj. Int J Nanomedicine. 2018 Mar 29;13:1927-1944. doi: 10.2147/IJN.S153107. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29636610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results